Free Trial

Beyond Air (XAIR) Stock Forecast & Price Target

Beyond Air logo
$0.50 -0.03 (-5.64%)
(As of 11/15/2024 ET)

Beyond Air - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
1
Buy
4

Based on 5 Wall Street analysts who have issued ratings for Beyond Air in the last 12 months, the stock has a consensus rating of "Buy." Out of the 5 analysts, 1 has given a hold rating, 3 have given a buy rating, and 1 has given a strong buy rating for XAIR.

Consensus Price Target

$3.67
631.14% Upside
According to the 5 analysts' twelve-month price targets for Beyond Air, the average price target is $3.67. The highest price target for XAIR is $8.00, while the lowest price target for XAIR is $1.00. The average price target represents a forecasted upside of 631.14% from the current price of $0.50.

XAIR Analyst Ratings Over Time

TypeCurrent Forecast
11/17/23 to 11/16/24
1 Month Ago
10/18/23 to 10/17/24
3 Months Ago
8/19/23 to 8/18/24
1 Year Ago
11/17/22 to 11/17/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$3.67$3.67$3.67$11.25
Forecasted Upside631.14% Upside962.80% Upside675.19% Upside650.00% Upside
Consensus Rating
Buy
Buy
Buy
Buy

XAIR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

XAIR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Beyond Air Stock vs. The Competition

TypeBeyond AirMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.80
2.50
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside631.14% Upside28,534.42% Upside9.94% Upside
News Sentiment Rating
Positive News

See Recent XAIR News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/16/2024Roth Capital
3 of 5 stars
J. Wittes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/16/2024Roth Mkm
1 of 5 stars
 Reiterated RatingBuy$2.00+433.32%
8/7/2024Piper Sandler
2 of 5 stars
 Lower TargetOverweight ➝ Overweight$3.50 ➝ $1.00+98.14%
6/25/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Thibault
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
4/30/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$10.00 ➝ $8.00+627.27%
6/23/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$16.00 ➝ $10.00+75.28%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 11:49 PM ET.


XAIR Forecast - Frequently Asked Questions

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Beyond Air is $3.67, with a high forecast of $8.00 and a low forecast of $1.00.

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Beyond Air in the last year. There is currently 1 hold rating, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" XAIR shares.

According to analysts, Beyond Air's stock has a predicted upside of 631.14% based on their 12-month stock forecasts.

Analysts like Beyond Air more than other "medical" companies. The consensus rating for Beyond Air is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how XAIR compares to other companies.


This page (NASDAQ:XAIR) was last updated on 11/16/2024 by MarketBeat.com Staff
From Our Partners